Optimized transglutaminase site-specific antibody conjugation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11786603
APP PUB NO 20190070306A1
SERIAL NO

16079851

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are methods and compositions for site-specific conjugation of antibodies in the presence of a transglutaminase.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • REGENERON PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
D'Souza, Christopher Pomona, US 2 0
Han, Amy Hockessin, US 64 545
Olson, William Yorktown Heights, US 77 864

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 17, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 17, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 17, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00